Form 4: Elevance Health Director Sells Shares, Cites Admin Error

Elevance Health Director Amy W. Schulman reported a late Form 4 filing detailing the sale of 26 common shares at $287.50 each, attributed to a broker's discretionary authority.

Summary

• Amy W. Schulman, a Director of Elevance Health, Inc. (ELV), reported a transaction involving the company's common stock.
• On March 12, 2026, 26 shares of common stock were sold at a price of $287.50 per share.
• Following this transaction, Amy W. Schulman beneficially owns 218 shares of Elevance Health common stock directly.
• The Form 4 filing was submitted late due to administrative errors and the transaction occurring under a broker's discretionary authority without the director's direct instruction or consent.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the late disclosure, administrative errors in reporting beneficial ownership, and an insider share sale, even though it was attributed to a broker's discretionary authority.

Negatives

• A director sold 26 shares of common stock.
• The Form 4 was filed late.
• The sale occurred without the director's consultation or consent, under a broker's discretionary authority, indicating a potential lack of direct control over some holdings.
• Administrative errors led to shares not being reflected in previous beneficial ownership totals.

Risks

• Potential for administrative errors in reporting insider holdings and transactions.
• Risk of transactions occurring without direct instruction or consent when discretionary accounts are involved, potentially leading to unexpected insider sales.
• Reputational risk associated with late filings and administrative errors in SEC disclosures.

Future Outlook

N/A

Management Comments

• This Form 4 is being filed late due to a combination of factors.
• The reported securities were acquired on behalf of the reporting person pursuant to broker discretionary authority prior to the reporting person joining the issuer's board.
• Due to administrative error, the shares were not reflected in previously reported beneficial ownership totals, including the balance reported following the equity award on February 2, 2026.
• The shares were sold on behalf of the reporting person pursuant to such discretionary authority, without consultation with or the consent of the reporting person, and the reporting person did not direct the specific transaction.
• This Form 4 is being filed promptly following discovery of the sale.

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 are standard disclosures, but the details regarding discretionary broker authority and administrative errors highlight the importance of robust internal controls for executive shareholdings, a common area of focus across all industries for corporate governance.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the late filing and administrative errors as a governance concern. An insider sale, even if involuntary, could be perceived negatively.
• Regulatory Authorities: The SEC requires timely and accurate filings; late filings and errors can lead to scrutiny.

Key Dates

Recommendation

The filing details a small insider sale attributed to a broker's discretionary authority and notes administrative errors leading to a late filing. While these are not ideal, the transaction size is minor relative to the company's market cap, and the issues appear to be administrative rather than indicative of fundamental business problems. Investors should monitor future filings for improved compliance, but this single event does not warrant a significant change in investment thesis.

Keywords

Elevance Health, ELV, Form 4, Insider Trading, Director Sale, Beneficial Ownership, SEC Filing, Amy W. Schulman